Alkermes plc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (30)

Latest Posts

About This Stock More About This Stock
Analyst Cuts Alkermes Rating As Cancer Drug Seems Less Effective Than Competitor
Article By: The Fly
Thursday, February 22, 2018 2:44 PM EDT
Shares of Alkermes are sliding after Jefferies analyst Biren Amin downgraded the stock to Hold as he believes the shares are fairly valued.
In this article: ALKS Also: NKTR
Read
Alkermes Rises After Nektar Said To Explore Sale
Article By: The Fly
Friday, February 2, 2018 4:12 PM EDT
Shares of Alkermes have been rising this afternoon after Bloomberg reported that another drugmaker exploring some of the same therapeutic areas, Nektar Therapeutics, is exploring its strategic options, including a potential sale.
In this article: ALKS, NKTR
Read
3 Pharma And Biotech Stocks To Watch Out For In 2018
Article By: Arpita Dutt
Monday, January 15, 2018 10:33 AM EDT
2017 turned out to be a pretty good year for pharma and biotech stocks with the Nasdaq Biotechnology index and the NYSE Arca Pharmaceutical index gaining 18.7% and 11.8%, respectively.
In this article: EIGR, XOMA, ALKS Also: NVS, BIIB
Read
Top Performing Stocks In January And Seasonality
Article By: Cory Mitchell, CMT
Sunday, December 31, 2017 11:33 AM EDT
January is not a good month for the stock market overall. The S&P 500 is usually flat to lower during the month. BUT, there are individual stocks that excel in January, rising at least 70% of the time and producing up to 17% gains during the month.
In this article: ALK, DIS, HRS, LEN, FAX, ALKS, CRUS, ERIC, XLNX, CYTR, EQC, OSK
Read
How To Generate A 10% Return In 45 Days
Article By: Greg Group
Thursday, July 6, 2017 6:18 AM EDT
ALKS has formed a pattern called Flag (Bullish), providing a target price for the short-term in the range of 61.50 to 62.30. We think the stock can hit the target price within 6 weeks or less.
In this article: ALKS
Read

PARTNER HEADLINES

Latest Tweets for $ALKS

No tweets yet!